Skip to main content

Anagrelide hydrochloride

Details of the Drug
Generic Name:
Anagrelide hydrochloride
an-AH-gre-lide  HYE-droe-KLOR-ide
Drug Type:
Platelet-reducing agent
How the Drug is Given:

By mouth

Anagrelide hydrochloride

Indications and Usage

Anagrelide hydrochloride is FDA approved for the treatment of patients with thrombocythemia, secondary to myeloproliferative disorders, to reduce the elevated platelet count and the risk of thrombosis and to improve associated symptoms including thrombo-hemorrhagic events (a process that involves either a blood clot or bleeding, such as a heart attack or stroke).

Side effects needing medical attention

Lack of strength; headache; fever; malaise; pain; abdominal pain; palpitations; faster than normal heartbeat; anorexia; diarrhea; indigestion; flatulence; nausea; vomiting; edema; dizziness; paresthesia (a skin sensation, such as burning, prickling, itching, or tingling, with no apparent physical cause); cough; shortness of breath; sore throat; itchy skin; rash. 

For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.